Comparison of Plasma Levels of Tryptophan Metabolites between Healthy People and Patients of Bipolar Depression at Various Age and Gender — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Comparison of Plasma Levels of Tryptophan Metabolites between Healthy People and Patients of Bipolar Depression at Various Age and Gender
Department of Psychiatry, Showa University Northern Yokohama Hospital, Yokohama, Japan
,
Global Application Development Center, Shimadzu Corporation, Kanagawa-ken, Japan
,
International Projects on Food and Health (NPO), Tokyo, Japan
,
Department of Psychiatry, Showa University School of Medicine, Tokyo, Japan
1 Department of Psychiatry, Showa University Northern Yokohama Hospital, Yokohama, Japan
2 Global Application Development Center, Shimadzu Corporation, Kanagawa-ken, Japan
3 International Projects on Food and Health (NPO), Tokyo, Japan
4 Department of Psychiatry, Showa University School of Medicine, Tokyo, Japan
Background: It is not well analyzed whether there are differences in plasma levels of tryptophan (TRP) metabolites between healthy control people (HC) and patients of type II bipolar depression (BDII). Methods: Ultra high-speed liquid chromatography/mass spectrometry has been used for the simultaneous determination of plasma levels of tryptophan metabolites in depressive patients. Results: Plasma levels of TRP are not different between HC and patients of BDII. Serotonin (5-HT) levels are higher in BDII than HC. Plasma levels of 5-HIAA of HC are higher than those of old women of BDII, but lower in young women of BDII. Plasma levels of kynurenine (KYN) of HC are not different from those of patients of BDII. Conclusion: Plasma levels of 5-HT are higher in patients of BDII than those of HC, which may suggest that use of drugs inhibiting the 5-HT transportation and lower transporter biding may increase plasma levels of 5-HT in patients of BD.
Baldessarini, R.J., Pérez, J., Salvatore, P., Trede, K. and Maggini, C. (2015) History of Bipolar Manic-Depressive Disorder. In: Yildiz, A., Ruiz, P., Nemeroff, C.B. and York, N., Eds., The Bipolar Book: History, Neurobiology, and Treatment, Oxford University Press, New York, 3-20. https://doi.org/10.1093/med/9780199300532.003.0001
Trede, K., Salvatore, P., Baethge, C., Gerhard, A., Maggini, C. and Baldessarini, R.J. (2005) Manic-Depressive Illness: Evolution in Kraepelins Textbook, 18831926. Harvard Review of Psychiatry, 13, 155-178. https://doi.org/10.1080/10673220500174833
Dunner, D.L., Stallone, F. and Fieve, R.R. (1976) Lithium Carbonate and Affective Disorders. V: A Double-Blind Study of Prophylaxis of Depression in Bipolar Illness. Archives of General Psychiatry, 33, 117-120. https://doi.org/10.1001/archpsyc.1976.01770010073014
Matsuoka, K., Kato, K., Takao, T., Ogawa, M., Ishii, Y., Shimizu, F., Masuda, J. and Takada, A. (2016) Concentrations of Various Tryptophan Metabolites Increase in Patients of Diabetes Mellitus Compared to Healthy Aged Male Adults. Diabetology International, 8, 69-72. https://doi.org/10.1007/s13340-016-0282-y
Takada, A., Shimizu, F. and Masuda, J. (2018) Measurement of Plasma Tryptophan Metabolites: Clinical and Experimental Application for Depression and Stress States Assessment. In: Melatonin—Molecular Biology, Clinical and Pharmaceutical Approaches, IntechOpen, London. https://doi.org/10.5772/intechopen.78560
Shimizu, F., Ishii, Y., Ogawa, M., Takao, T., Matsuoka, K., Kato, K. and Takada, A. (2018) Plasma Levels of Tryptophan Metabolites in Healthy Young and Old Men and Women, and Patients of Type 2 Diabetes Mellitus (T2DM). Obesity: Open Access, 4, 1-9. https://doi.org/10.16966/2380-5528.138
Takada, A., Shimizu, F. and Masuda, J. (2019) Plasma Levels of Tryptophan Metabolites in Patients of Type 2 Diabetes Mellitus. In: Watson, R. and Preedy, V., Eds., Bioactive Food as Dietary Interventions for Diabetes, 2nd Edition, Academic Press, Cambridge, 265-276. https://doi.org/10.1016/B978-0-12-813822-9.00017-5
Tomioka, H., Masuda, J., Takada, A. and Iwanami, A. (2020) Comparison Age and Gender Differences of Tryptophan Metabolites in Patients of Major Monopolar and Bipolar Depression. Foods and Nutrition Science, 11, 172-185. https://doi.org/10.4236/fns.2020.113013
Tomioka, H., Masuda, J., Takada, A. and Iwanami, A. (2020) Differences of Plasma Levels of Tryptophan, Serotonin, 5-Hydroxyindole Acetic Acid, and Kynurenine between Healthy People and Patients of Major Monopolar Depression at Various Age and Gender. Foods and Nutrition Science, 11, 431-441.
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM-5). APA, Washington DC. https://doi.org/10.1176/appi.books.9780890425596
Guy, W. (1976) Clinical Global Impressions ECDEU Assessment Manual for Psychopharmacology, Revised (DHEW Publ. No. ADM 76-338). National Institute of Mental Health, Rockville, 218-222. https://doi.org/10.1037/e591322011-001
Zung, W.W.K. (1965) A Self-Rating Depression Scale. Archives of General Psychiatry, 12, 63-70. https://doi.org/10.1001/archpsyc.1965.01720310065008
Hamilton, M. (1960) A Rating Scale for Depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56-62. https://doi.org/10.1136/jnnp.23.1.56
Mantere, O., Suominen, K., Valtonen, H.M., et al. (2008) Differences in Outcome of DSM-IV Bipolar I and II Disorders. Bipolar Disorders, 10, 413-425. https://doi.org/10.1111/j.1399-5618.2007.00502.x
Maina, G., Albert, U., Bellodi, L., et al. (2007) Health-Related Quality of Life in Euthymic Bipolar Disorder Patients: Differences between Bipolar I and II Subtypes. Journal of Clinical Psychiatry, 68, 207-212. https://doi.org/10.4088/JCP.v68n0205
Angst, J., Gamma, A., Benazzi, F., Ajdacic, V., Eich, D. and Rossler, W. (2003) Toward a Re-Definition of Subthreshold Bipolarity: Epidemiology and Proposed Criteria for Bipolar-II, Minor Bipolar Disorders and Hypomania. Journal of Affective Disorders, 73, 133-146. https://doi.org/10.1016/S0165-0327(02)00322-1
Swartz, H.A. and Thase, M.E. (2011) Pharmacotherapy for the Treatment of Acute Bipolar II Depression: Current Evidence. Journal of Clinical Psychiatry, 72, 356-366. https://doi.org/10.4088/JCP.09r05192gre
Salvi, V., Fagiolini, A., Swartz, H.A., Maina, G. and Frank, E. (2008) The Use of Antidepressants in Bipolar Disorder. Journal of Clinical Psychiatry, 69, 1307-1318. https://doi.org/10.4088/JCP.v69n0816
Sachs, G.S., Nierenberg, A.A., Calabrese, J.R., et al. (2007) Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression. New England Journal of Medicine, 356, 1711-1722. https://doi.org/10.1056/NEJMoa064135
Tomioka, H., Masuda, J., Takada, A. and Iwanami, A. (2020) Differences of Plasma Levels of Tryptophan, Serotonin, 5-Hydroxyindole Acetic Acid, and Kynurenine between Healthy People and Patients of Major Monopolar Depression at Various Age and Gender. Food and Nutrition Sciences, 11, 431-441.
Artigas, F., Sarrias, M.J., Martínez, E., Gelpí, E., Alvarez, E. and Udina, C. (1989) Increased Plasma Free Serotonin But Unchanged Platelet Serotonin in Bipolar Patients Treated Chronically with Lithium. Psychopharmacology (Berl.), 99, 328-332. https://doi.org/10.1007/BF00445552
Ortiz, J. and Artigas, F. (1992) Effects of Monoamine Uptake Inhibitors on Extracellular and Platelet 5-Hydroxytryptamine in Rat Blood: Different Effects of Clomipramine and Fluoxetine. British Journal of Pharmacology, 105, 941-946. https://doi.org/10.1111/j.1476-5381.1992.tb09082.x
Hrdina, P.D., Bakish, D., Chudzik, J., Ravindran, A. and Lapierre, Y.D. (1995) Serotonergic Markers in Platelets of Patients with Major Depression: Upregulation of 5-HT2 Receptors. Journal of Psychiatry & Neuroscience, 20, 11-19.
Giurgiuca, A., Schipor, S., Caragheorgheopol, A., Crasan, A., Postolache, E., Tudose, C., Prelipceanu, D. and Cozman, D. (2016) Platelet Serotonin as Biomarker for Assessing Suicidal Behaviour in Patients with Bipolar I Disorder. Acta Endocrinologica (Bucharest), 12, 275-281. https://doi.org/10.4183/aeb.2016.275
Fieve, R.R., Kumbaraci, T. and Dunner, D.L. (1976) Lithium Prophylaxis of Depression in Bipolar I, Bipolar II, and Unipolar Patients. American Journal of Psychiatry, 133, 925-929. https://doi.org/10.1176/ajp.133.8.925
Kane, J.M., et al. (1982) Lithium Carbonate and Imipramine in the Prophylaxis of Unipolar and Bipolar II Illness: A Prospective, Placebo-Controlled Comparison. Archives of General Psychiatry, 39, 1065-1069. https://doi.org/10.1001/archpsyc.1982.04290090053011
Tondo, L., Baldessarini, R.J., Hennen, J. and Floris, G. (1998) Lithium Maintenance Treatment of Depression and Mania in Bipolar I and Bipolar II Disorders. American Journal of Psychiatry, 155, 638-645. https://doi.org/10.1176/ajp.155.5.638
Asberg, M., Träskman, L. and Thoren, P. (1976) 5-HIAA in the Cerebrospinal Fluid. A Biochemical Suicide Predictor? Archives of General Psychiatry, 33, 1193-1197. https://doi.org/10.1001/archpsyc.1976.01770100055005
Träskman, L., Asberg, M., Bertilsson, L. and Sjöstrand, L. (1981) Monoamine Metabolites in CSF and Suicidal Behavior. Archives of General Psychiatry, 38, 631-636. https://doi.org/10.1001/archpsyc.1981.01780310031002
Jokinen, J., Nordström, A.L. and Nordström, P. (2009) CSF 5-HIAA and DST Non-Suppression: Orthogonal Biologic Risk Factors for Suicide in Male Mood Disorder in Patients. Psychiatry Research, 165, 96-102. https://doi.org/10.1016/j.psychres.2007.10.007
Bach, H., Huang, Y.Y., Underwood, M.D., Dwork, A.J., Mann, J.J. and Arango, V. (2014) Elevated Serotonin and 5-HIAA in the Brainstem and Lower Serotonin Turnover in the Prefrontal Cortex of Suicides. Synapse, 68, 127-130. https://doi.org/10.1002/syn.21695
Owen, F., Chambers, D.R., Cooper, S.J., Crow, T.J., Johnson, J.A., Lofthouse, R. and Poulter, M. (1986) Serotonergic Mechanisms in Brains of Suicide Victims. Brain Research, 362, 185-188. https://doi.org/10.1016/0006-8993(86)91415-0
Cheetham, S.C., Crompton, M.R., Czudek, C., Horton, R.W., Katona, C.L. and Reynolds, G.P. (1989) Serotonin Concentrations and Turnover in Brains of Depressed Suicides. Brain Research, 502, 332-340. https://doi.org/10.1016/0006-8993(89)90629-X
Arango, V., Underwood, M.D., Gubbi, A.V. and Mann, J.J. (1995) Localized Alterations in Pre- and Postsynaptic Serotonin Binding Sites in the Ventrolateral Prefrontal Cortex of Suicide Victims. Brain Research, 688, 121-133. https://doi.org/10.1016/0006-8993(95)00523-S
Dinan, T.G. and Cryan, J.F. (2013) Melancholic Microbes: A Link between Gut Microbiota and Depression? Neurogastroenterology & Motility, 25, 713-719. https://doi.org/10.1111/nmo.12198
Aizawa, E., Tsuji, H., Asahara, T., Takahashi, T., Teraishi, T., Yoshida, S., Ota, M., Koga, N., Hattori, K. and Kunugi, H. (2016) Possible Association of Bifidobacterium and Lactobacillus in the Gut Microbiota of Patients with Major Depressive Disorder. Journal of Affective Disorders, 202, 254-257. https://doi.org/10.1016/j.jad.2016.05.038
Pennisi, E. (2020) Meet the Psychobiome. Science, 368, 570-573. https://doi.org/10.1126/science.368.6491.570